Mostrar el registro sencillo del ítem

dc.creatorPateraki G., Anargyros K., Aloizou A.-M., Siokas V., Bakirtzis C., Liampas I., Tsouris Z., Ziogka P., Sgantzos M., Folia V., Peristeri E., Dardiotis E.en
dc.date.accessioned2023-01-31T09:46:13Z
dc.date.available2023-01-31T09:46:13Z
dc.date.issued2022
dc.identifier10.1016/j.jelekin.2021.102622
dc.identifier.issn10506411
dc.identifier.urihttp://hdl.handle.net/11615/77973
dc.description.abstractTranscranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that makes use of the magnetic field generated when an electric current passes through a magnetic coil placed over the scalp. It can be applied as a single stimulus at a time, in pairs of stimuli, or repetitively in trains of stimuli (repetitive TMS, rTMS). RTMS can induce changes in brain activity, whose after-effects reflect the processes of long-term potentiation and long-term depression, as certain protocols, namely those using low frequencies (≤1 Hz) seem to suppress cortical excitability, while those using high frequencies (>1 Hz) seem to enhance it. It is a technique with very few and mostly mild side-effects, whose effects can persist for long time periods, and as such, it has been studied as a potential treatment option in a multitude of neurodegenerative diseases, including those affecting movement. Although rTMS has received approval as a treatment strategy of only a few aspects in movement disorders in the latest guidelines, its further use seems to also be promising in their context. In this review, we gathered the available literature on the therapeutic application of rTMS in movement disorders, namely Parkinson's disease, Amyotrophic Lateral Sclerosis, Huntington's disease, Dystonia, Tic disorders and Essential Tremor. © 2021 Elsevier Ltden
dc.language.isoenen
dc.sourceJournal of Electromyography and Kinesiologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85120615853&doi=10.1016%2fj.jelekin.2021.102622&partnerID=40&md5=9ab686d238c7df78d18fcbf8bacd8658
dc.subjectantidepressant agenten
dc.subjectbrain derived neurotrophic factoren
dc.subjectfluoxetineen
dc.subjectlevodopaen
dc.subjectamyotrophic lateral sclerosisen
dc.subjectArticleen
dc.subjectbrain regionen
dc.subjectdegenerative diseaseen
dc.subjectdepressionen
dc.subjectdystoniaen
dc.subjectessential tremoren
dc.subjectfunctional magnetic resonance imagingen
dc.subjecthumanen
dc.subjectHuntington choreaen
dc.subjectmood disorderen
dc.subjectmotor dysfunctionen
dc.subjectneuromuscular functionen
dc.subjectParkinson diseaseen
dc.subjectquality of lifeen
dc.subjectrepetitive transcranial magnetic stimulationen
dc.subjectticen
dc.subjecttreatment durationen
dc.subjecttreatment outcomeen
dc.subjecttreatment responseen
dc.subjectUnified Parkinson Disease Rating Scaleen
dc.subjectmotor cortexen
dc.subjectmovement (physiology)en
dc.subjectParkinson diseaseen
dc.subjectskeletal muscleen
dc.subjecttranscranial magnetic stimulationen
dc.subjectHumansen
dc.subjectMotor Cortexen
dc.subjectMovementen
dc.subjectMuscle, Skeletalen
dc.subjectParkinson Diseaseen
dc.subjectTranscranial Magnetic Stimulationen
dc.subjectElsevier Ltden
dc.titleTherapeutic application of rTMS in neurodegenerative and movement disorders: A reviewen
dc.typejournalArticleen


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem